Global Health Limited has informed the Exchange about Capacity addition

Capex & Operations View source PDF Explain this filing

MEDANTA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+6.3%Reaction day

₹1100.10

prior close

₹1157.05

announcement price

In-mkt

timing

Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)+1.5%+4.9% vs market

Hospital peers, median of 24sector+1.5%+4.8% vs sector

On the reaction day the stock moved 4.9 pts more than Nifty Midcap 150 and 4.8 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.5

10m

+0.4

15m

+0.5

30m

+1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+6.3+1.5+4.9+1.5+4.8

Next day

+3.0+1.6+1.4+0.9+2.1

+3.3+1.5+1.7+0.3+3.0

+1.8+0.6+1.2+0.2+1.6

+6.4+1.3+5.1+2.5+3.8

+6.5+1.4+5.1+2.1+4.4

+10.4+4.2+6.1+2.9+7.4

15d

+12.2+2.3+9.9+3.9+8.3

+10.2+4.6+5.6+5.0+5.2

+18.3+3.7+14.6+8.1+10.2

+28.3+4.8+23.4+12.4+15.8

UpDownMarket · Nifty Midcap 150Sector · Hospital peers, median of 24Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Global Health Limited (Medanta) has approved acquisition of a 79-bedded Cancer Care Hospital in Indore from Asian Institute of Oncology Private Limited for Rs. 30 crores. The target hospital, currently operated by AIOPL, had turnover of Rs. 19.9 million in FY 2024-25. Medanta's existing capacity is 3,579 beds as of March 31, 2026. The hospital is located just 500 meters from Medanta's existing Indore facility and is purpose-built for oncology services. The acquisition will be funded through internal accruals and debt funding, with expected completion before September 30, 2026 subject to statutory approvals.

Likely market impact

This acquisition adds 79 beds (~2.2% increase) and strengthens Medanta's oncology portfolio in Indore, creating operational synergies through proximity to the existing facility. The transaction is not a related party deal and expands the company's tertiary/quaternary care services.